Table 4. Factors associated with DMFS by multivariate analysis in 650 patients.
Abbreviations: Hb = hemoglobin; RR = relative risk; CI = confidence interval; ΔHb = individual differences between pre-treatment hemoglobin and post-treatment.
| P | RR | 95.0% CI | |
|---|---|---|---|
| Gender | 0.042 | 1.854 | 1.023–3.359 |
| Age | 0.860 | 0.959 | 0.603–1.526 |
| Pre-treatment Hb | 0.007 | 2.555 | 1.294–5.046 |
| Mid-treatment Hb | 0.218 | 1.438 | 0.806–2.564 |
| Post-treatment Hb | 0.341 | 0.727 | 0.376–1.403 |
| Hb continuous decrease | 0.117 | 1.709 | 0.874–3.341 |
| ΔHb | 0.237 | 0.715 | 0.410–1.247 |
| T stage | 0.610 | 0.846 | 0.445–1.608 |
| N stage | 0.266 | 1.370 | 0.786–2.389 |
| Clinical stage | 0.998 | 1.001 | 0.331–3.028 |
| EBV DNA | <0.001 | 3.135 | 1.898–5.179 |